ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 922

Anakinra Treatment Prevents Myocardial Mechanical Dysfunction and Inhibits Histologic Evidence of Myocardial Inflammation in the Mouse Model of Kawasaki Disease

Mark Gorelik1,2, Youngho Lee3, Masanori Abe4, Thomas Andrews5, Jean Patterson1, Magali Noval Rivas4, Gregory Aune5 and Moshe Arditi4, 1Immunology and Virology, Texas Biomedical Research Institute, San Antonio, TX, 2Pediatrics, Baylor College of Medicine, Houston, TX, 3Department of Cell Biology, Hospital for Sick Children, Toronto, ON, Canada, 4Pediatrics, Cedars Sinai, Beverly Hills, CA, 5Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: anakinra and histopathologic, Imaging, Kawasaki disease, MRI

Session Information

Date: Sunday, October 21, 2018

Title: 3S106 ACR Abstract: Pediatric Rheumatology–Basic Science (922–927)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Kawasaki disease (KD) is an acute, febrile illness of childhood with sequelae of coronary artery aneurysms and cardiac fibrosis, and is the most common cause of acquired heart disease among children in the developed world. Acutely, a subset of patients with KD will demonstrate echocardiographic evidence of impaired myocardial function, as well as increased left ventricular mass presumed to be due to myocardial edema and inflammation. Further, some patients will develop profound cardiac dysfunction known as Kawasaki Shock Syndrome. Here, we investigated whether inhibition of interleukin-1 activity via anakinra would correct development of the myocardial mechanical dysfunction and myocardial inflammation seen in KD.

Methods: KD was induced via the established model of lactobacillus casei cell wall extract (LCWE) injection in 4-6 week old male mice. For echocardiography and MRI, groups of mice either injected with LCWE alone, LCWE and anakinra, or normal controls were compared. Myocardial inflammation was scored by a blinded pathologist.

Results: Both imaging modalities demonstrated normalized left ventricular function in anakinra treated KD mice via measurements of ejection fraction, fractional shortening (echo) and end diastolic and systolic volumes (MRI). These were significantly (p<0.05) normalized as compared to untreated diseased KD mice. Additionally, while KD mice demonstrated increased left ventricular mass index, this was markedly attenuated (p<0.01) in anakinra treated mice. Myocardial inflammation scores were significantly (p<0.05) lower in anakinra treated vs. untreated mice.

Conclusion: Anti-interleukin-1 therapy in the mouse model of KD prevents the development of myocardial mechanical dysfunction and left ventricular mass enlargement as well as myocardial inflammatory changes. This demonstrates functional efficacy of this therapy in the treatment of children with KD, and also raises the clinical implication of anakinra treatment in patients with severe cardiac dysfunction of Kawasaki Shock Syndrome. Additionally, the demonstration of these findings in the mouse model of KD greatly bolsters the applicability of this model for human KD.


Disclosure: M. Gorelik, None; Y. Lee, None; M. Abe, None; T. Andrews, None; J. Patterson, None; M. Noval Rivas, None; G. Aune, None; M. Arditi, None.

To cite this abstract in AMA style:

Gorelik M, Lee Y, Abe M, Andrews T, Patterson J, Noval Rivas M, Aune G, Arditi M. Anakinra Treatment Prevents Myocardial Mechanical Dysfunction and Inhibits Histologic Evidence of Myocardial Inflammation in the Mouse Model of Kawasaki Disease [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/anakinra-treatment-prevents-myocardial-mechanical-dysfunction-and-inhibits-histologic-evidence-of-myocardial-inflammation-in-the-mouse-model-of-kawasaki-disease/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anakinra-treatment-prevents-myocardial-mechanical-dysfunction-and-inhibits-histologic-evidence-of-myocardial-inflammation-in-the-mouse-model-of-kawasaki-disease/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology